139 related articles for article (PubMed ID: 26068693)
1. The crux of the matter: Did the ABC's Catalyst program change statin use in Australia?
Schaffer AL; Buckley NA; Dobbins TA; Banks E; Pearson SA
Med J Aust; 2015 Jun; 202(11):591-5. PubMed ID: 26068693
[TBL] [Abstract][Full Text] [Related]
2. Passing the acid test? Evaluating the impact of national education initiatives to reduce proton pump inhibitor use in Australia.
Bruno C; Pearson SA; Daniels B; Buckley NA; Schaffer A; Zoega H
BMJ Qual Saf; 2020 May; 29(5):365-373. PubMed ID: 31641029
[TBL] [Abstract][Full Text] [Related]
3. Predictors of statin use among older adults: A nationwide cross-sectional study.
Ofori-Asenso R; Ilomäki J; Tacey M; Zomer E; Curtis AJ; Bell JS; Zoungas S; Liew D
J Clin Lipidol; 2019; 13(1):156-162.e1. PubMed ID: 30446321
[TBL] [Abstract][Full Text] [Related]
4. A 10-Year Trend in Statin Use Among Older Adults in Australia: an Analysis Using National Pharmacy Claims Data.
Ofori-Asenso R; Ilomäki J; Zomer E; Curtis AJ; Zoungas S; Liew D
Cardiovasc Drugs Ther; 2018 Jun; 32(3):265-272. PubMed ID: 29790056
[TBL] [Abstract][Full Text] [Related]
5. Impact of NPS MedicineWise general practitioner education programs and Choosing Wisely Australia recommendations on prescribing of proton pump inhibitors in Australia.
Wu J; Dickinson S; Elgebaly Z; Blogg S; Heaney A; Soo Y; Daniels B; Weekes L
BMC Fam Pract; 2020 May; 21(1):85. PubMed ID: 32386520
[TBL] [Abstract][Full Text] [Related]
6. Patterns of statin use and long-term adherence and persistence among older adults with diabetes.
Ofori-Asenso R; Ilomäki J; Tacey M; Zomer E; Curtis AJ; Bell JS; Zoungas S; Liew D
J Diabetes; 2018 Sep; 10(9):699-707. PubMed ID: 29658177
[TBL] [Abstract][Full Text] [Related]
7. Frequent general practitioner visits are protective against statin discontinuation after a Pharmaceutical Benefits Scheme copayment increase.
Seaman KL; Sanfilippo FM; Bulsara MK; Brett T; Kemp-Casey A; Roughead EE; Bulsara C; Preen DB
Aust Health Rev; 2020 Jun; 44(3):377-384. PubMed ID: 32389176
[TBL] [Abstract][Full Text] [Related]
8. The potential influence of various initiatives to improve rational prescribing for proton pump inhibitors and statins in Belgium.
Fraeyman J; Van Hal G; Godman B; Beutels P
Expert Rev Pharmacoecon Outcomes Res; 2013 Feb; 13(1):141-51. PubMed ID: 23402454
[TBL] [Abstract][Full Text] [Related]
9. Predictors of first-year nonadherence and discontinuation of statins among older adults: a retrospective cohort study.
Ofori-Asenso R; Ilomäki J; Tacey M; Si S; Curtis AJ; Zomer E; Bell JS; Zoungas S; Liew D
Br J Clin Pharmacol; 2019 Jan; 85(1):227-235. PubMed ID: 30402916
[TBL] [Abstract][Full Text] [Related]
10. The impact of co-payment increases on dispensings of government-subsidised medicines in Australia.
Hynd A; Roughead EE; Preen DB; Glover J; Bulsara M; Semmens J
Pharmacoepidemiol Drug Saf; 2008 Nov; 17(11):1091-9. PubMed ID: 18942671
[TBL] [Abstract][Full Text] [Related]
11. Impact of consumer copayments for subsidised medicines on health services use and outcomes: a protocol using linked administrative data from Western Australia.
Seaman KL; Sanfilippo FM; Roughead EE; Bulsara MK; Kemp-Casey A; Bulsara C; Watts GF; Preen D
BMJ Open; 2017 Jun; 7(6):e013691. PubMed ID: 28637723
[TBL] [Abstract][Full Text] [Related]
12. Cost driver analysis of statin expenditure on Australia's Pharmaceutical Benefits Scheme.
Thai LP; Moss JR; Godman B; Vitry AI
Expert Rev Pharmacoecon Outcomes Res; 2016 Jun; 16(3):419-33. PubMed ID: 26707482
[TBL] [Abstract][Full Text] [Related]
13. Four out of ten patients are not taking statins regularly during the 12 months after an acute coronary event.
Thornley S; Marshall R; Chan WC; Kerr A; Harrison J; Jackson G; Crengle S; Wright C; Wells S; Jackson R
Eur J Prev Cardiol; 2012 Jun; 19(3):349-57. PubMed ID: 21450568
[TBL] [Abstract][Full Text] [Related]
14. Quantifying the use of the statin antilipemic drugs: comparisons and contrasts between Nova Scotia, Canada, and Queensland, Australia.
Cooke C; Nissen L; Sketris I; Tett SE
Clin Ther; 2005 Apr; 27(4):497-508. PubMed ID: 15922822
[TBL] [Abstract][Full Text] [Related]
15. The impact of tightened prescribing restrictions on proton pump inhibitor use in Australia: An evaluation using interrupted time series analysis.
Daniels B; Schaffer A; Buckley NA; Bruno C; Jun M; Pearson SA; Zoega H
Pharmacoepidemiol Drug Saf; 2022 Mar; 31(3):370-378. PubMed ID: 34894368
[TBL] [Abstract][Full Text] [Related]
16. Increased patient co-payments and changes in PBS-subsidised prescription medicines dispensed in Western Australia.
Hynd A; Roughead EE; Preen DB; Glover J; Bulsara M; Semmens J
Aust N Z J Public Health; 2009 Jun; 33(3):246-52. PubMed ID: 19630844
[TBL] [Abstract][Full Text] [Related]
17. Long-term use of statins and risk of colorectal cancer: a population-based study.
Singh H; Mahmud SM; Turner D; Xue L; Demers AA; Bernstein CN
Am J Gastroenterol; 2009 Dec; 104(12):3015-23. PubMed ID: 19809413
[TBL] [Abstract][Full Text] [Related]
18. Statin prescribing in Australia: socioeconomic and sex differences. A cross-sectional study.
Stocks NP; Ryan P; McElroy H; Allan J
Med J Aust; 2004 Mar; 180(5):229-31. PubMed ID: 14984343
[TBL] [Abstract][Full Text] [Related]
19. Lipid monitoring in a community cohort of people taking statins: who is tested and is testing associated with subsequent alteration in therapy?
Beadel H; Halim A; Bridgford P; Hudson B
N Z Med J; 2020 Jul; 133(1518):54-63. PubMed ID: 32683432
[TBL] [Abstract][Full Text] [Related]
20. Demographic, clinical and lifestyle factors associated with high-intensity statin therapy in Australia: the AusDiab study.
Ho K; Jamsen KM; Bell JS; Korhonen MJ; Mc Namara KP; Magliano DJ; Liew D; Ryan-Atwood TE; Shaw JE; Luc S; Ilomäki J
Eur J Clin Pharmacol; 2018 Nov; 74(11):1493-1501. PubMed ID: 30027413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
